| Eli Lilly And Company | 456K | US$546M | 9.4% |
| Johnson & Johnson | 1.62M | US$412M | 7.1% |
| Abbvie Inc. | 1.08M | US$271M | 4.7% |
| Unitedhealth Group Incorporated | 634K | US$264M | 4.5% |
| Astrazeneca Plc | 1.22M | US$228M | 3.9% |
| Revolution Medicines, Inc. | 937K | US$175M | 3.0% |
| Argenx Se | 165K | US$153M | 2.6% |
| Novartis Ag | 952K | US$149M | 2.6% |
| Thermo Fisher Scientific Inc | 270K | US$135M | 2.3% |
| Praxis Precision Medicines, Inc. | 379K | US$127M | 2.2% |
| Bridgebio Pharma, Inc. | 1.59M | US$118M | 2.0% |
| Cvs Health Corporation | 1.13M | US$117M | 2.0% |
| Roche Holding Ltd | 284K | US$117M | 2.0% |
| Intuitive Surgical, Inc. | 284K | US$113M | 1.9% |
| Merck & Company, Inc. | 847K | US$109M | 1.9% |
| Abbott Laboratories | 1.19M | US$108M | 1.9% |
| Vertex Pharmaceuticals Incorporated | 198K | US$98.3M | 1.7% |
| Ascendis Pharma A/s | 365K | US$97.5M | 1.7% |
| Danaher Corporation | 502K | US$95.7M | 1.6% |
| Amgen Inc. | 263K | US$95.1M | 1.6% |
| Sanofi Sa | 1.07M | US$91.8M | 1.6% |
| Stryker Corporation | 260K | US$82M | 1.4% |
| Ptc Therapeutics, Inc. | 996K | US$81.2M | 1.4% |
| Gilead Sciences, Inc. | 637K | US$80.5M | 1.4% |
| Travere Therapeutics, Inc. | 1.41M | US$80.3M | 1.4% |
| Madrigal Pharmaceuticals, Inc. | 145K | US$78.1M | 1.3% |
| Hca Healthcare, Inc. | 188K | US$73.5M | 1.3% |
| Mirum Pharmaceuticals, Inc. | 559K | US$65.4M | 1.1% |
| Boston Scientific Corporation | 1.53M | US$65.3M | 1.1% |
| Teva Pharmaceutical Industries Limited | 1.88M | US$63.8M | 1.1% |
| United Therapeutics Corporation | 115K | US$62.2M | 1.1% |
| Elevance Health, Inc. | 157K | US$60.6M | 1.0% |
| Globus Medical, Inc. | 744K | US$58.8M | 1.0% |
| Lantheus Holdings, Inc. | 508K | US$56.4M | 0.97% |
| Mckesson Corporation | 73,813 | US$55.8M | 0.96% |
| Vaxcyte, Inc. | 942K | US$54.8M | 0.94% |
| Dyne Therapeutics, Inc. | 2.27M | US$50.5M | 0.87% |
| Edwards Lifesciences Corporation | 501K | US$45.3M | 0.78% |
| Medtronic Plc. | 550K | US$43M | 0.74% |
| Cencora, Inc. | 123K | US$34.9M | 0.60% |
| Ucb S.a. | 113K | US$33.8M | 0.58% |
| Medline Inc. | 851K | US$33.6M | 0.58% |
| Definium Therapeutics, Inc. | 710K | US$33.4M | 0.58% |
| Insmed Incorporated | 306K | US$32.6M | 0.56% |
| Dexcom, Inc. | 462K | US$31.1M | 0.54% |
| Spyre Therapeutics, Inc. | 329K | US$29.2M | 0.50% |
| Ideaya Biosciences, Inc. | 758K | US$28.2M | 0.49% |
| Glaukos Corporation | 197K | US$27.5M | 0.47% |
| Apogee Therapeutics, Inc. | 207K | US$27.5M | 0.47% |
| Edgewise Therapeutics, Inc. | 677K | US$27.5M | 0.47% |
| Becton, Dickinson And Company | 176K | US$26.6M | 0.46% |
| Abivax Sa | 179K | US$23.9M | 0.41% |
| Neurocrine Biosciences, Inc. | 135K | US$22.7M | 0.39% |
| Tarsus Pharmaceuticals, Inc. | 347K | US$21.8M | 0.38% |
| Centene Corporation | 330K | US$21.2M | 0.37% |
| Oruka Therapeutics, Inc. | 222K | US$21.1M | 0.36% |
| Xenon Pharmaceuticals Inc. | 334K | US$20.2M | 0.35% |
| Cogent Biosciences, Inc. | 519K | US$20.1M | 0.35% |
| Biohaven Ltd. | 1.33M | US$19.8M | 0.34% |
| The Cooper Companies, Inc. | 267K | US$19.1M | 0.33% |
| Tango Therapeutics, Inc. | 586K | US$18.3M | 0.32% |
| Heartflow, Inc. | 618K | US$18.1M | 0.31% |
| Sotera Health Company | 1.01M | US$18M | 0.31% |
| Scholar Rock Holding Corporation | 325K | US$17.9M | 0.31% |
| Insulet Corporation | 116K | US$17.7M | 0.30% |
| Rhythm Pharmaceuticals, Inc. | 158K | US$17.6M | 0.30% |
| Humana Inc. | 44,118 | US$17.5M | 0.30% |
| Steris Plc (ireland) | 79,117 | US$16.7M | 0.29% |
| Illumina, Inc. | 92,732 | US$16.3M | 0.28% |
| Jade Biosciences, Inc. | 717K | US$15.9M | 0.27% |
| Daiichi Sankyo Company, Limited | 966K | US$15.5M | 0.27% |
| Penumbra, Inc. | 47,535 | US$15M | 0.26% |
| Protagonist Therapeutics, Inc. | 118K | US$14.4M | 0.25% |
| Crinetics Pharmaceuticals, Inc. | 377K | US$14.1M | 0.24% |
| Regeneron Pharmaceuticals, Inc. | 22,132 | US$13.8M | 0.24% |
| Alnylam Pharmaceuticals, Inc. | 41,334 | US$12.4M | 0.21% |
| Teleflex Incorporated | 92,684 | US$11.7M | 0.20% |
| Ardelyx, Inc. | 2.17M | US$11.1M | 0.19% |
| 4d Molecular Therapeutics, Inc. | 788K | US$10.5M | 0.18% |
| Parabilis Medicines, Inc. | 313K | US$8.57M | 0.15% |
| Olema Pharmaceuticals, Inc. | 658K | US$8.23M | 0.14% |
| Lexeo Therapeutics, Inc. | 561K | US$2.61M | 0.04% |
| Immunome, Inc. | 0 | US$0 | 0.00% |
| Janux Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Zoetis Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |